Futility studies - Spending a little to save a lot

被引:22
作者
Schwid, SR
Cutter, GR
机构
[1] Univ Rochester, Dept Neurol Neuroimmunol, Rochester, NY 14642 USA
[2] Univ Alabama Birmingham, Birmingham Dept Stat, Birmingham, AL USA
关键词
D O I
10.1212/01.wnl.0000204644.81956.65
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:626 / 627
页数:2
相关论文
共 8 条
[1]   A two-stage design for a phase II clinical trial of coenzyme Q10 in ALS [J].
Levy, G ;
Kaufmann, P ;
Buchsbaum, R ;
Montes, J ;
Barsdorf, A ;
Arbing, R ;
Battista, V ;
Zhou, X ;
Mitsumoto, H ;
Levin, B ;
Thompson, JLP .
NEUROLOGY, 2006, 66 (05) :660-663
[2]   Biomarkers and Surrogate Outcomes in Neurodegenerative Disease: Lessons from Multiple Sclerosis [J].
Miller D.H. .
NeuroRX, 2004, 1 (2) :284-294
[3]   Diagnostic criteria for multiple sclerosis: 2005 Revisions to the "McDonald Criteria" [J].
Polman, CH ;
Reingold, SC ;
Edan, G ;
Filippi, M ;
Hartung, HP ;
Kappos, L ;
Lublin, FD ;
Metz, LM ;
McFarland, HF ;
O'Connor, PW ;
Sandberg-Wollheim, M ;
Thompson, AJ ;
Weinshenker, BG ;
Wolinsky, JS .
ANNALS OF NEUROLOGY, 2005, 58 (06) :840-846
[4]  
Ravina B, 2006, NEUROLOGY, V66, P664
[5]   Are quantitative functional measures more sensitive to worsening MS than traditional measures? [J].
Schwid, SR ;
Goodman, AD ;
Apatoff, BR ;
Coyle, PK ;
Jacobs, LD ;
Krupp, LB ;
Miller, AE ;
Wende, KE ;
Brownscheidle, CM .
NEUROLOGY, 2000, 55 (12) :1901-1903
[6]   NEW DESIGNS FOR THE SELECTION OF TREATMENTS TO BE TESTED IN RANDOMIZED CLINICAL-TRIALS [J].
SIMON, R ;
THALL, PF ;
ELLENBERG, SS .
STATISTICS IN MEDICINE, 1994, 13 (5-7) :417-429
[7]   Optimizing the ongoing search for new treatments for Parkinson disease - Using futility designs [J].
Tilley, BC ;
Palesch, YY ;
Kieburtz, K ;
Ravina, B ;
Huang, P ;
Elm, JJ ;
Shannon, K ;
Wooten, GF ;
Tanner, CM ;
Goetz, GC .
NEUROLOGY, 2006, 66 (05) :628-633
[8]  
Whitaker J N, 1995, Mult Scler, V1, P37